Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macu...

por Huber, Anna Lena, Angermann, Reinhard, Nowosielski, Yvonne, Seifarth, Christof, Kralinger, Martina T., Zehetner, Claus
Publicado 2021

Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential fa...

por Angermann, Reinhard, Huber, Anna Lena, Hofer, Markus, Nowosielski, Yvonne, Egger, Stefan, Kralinger, Martina T, Zehetner, Claus
Publicado 2021

CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

por Angermann, Reinhard, Huber, Anna Lena, Nowosielski, Yvonne, Salcher, Stefan, Gasser, Thomas, Seifarth, Christof, Kralinger, Martina T., Zehetner, Claus
Publicado 2022

The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48‐month follow‐up study

por Angermann, Reinhard, Hofer, Markus, Huber, Anna Lena, Rauchegger, Teresa, Nowosielski, Yvonne, Casazza, Marina, Falanga, Valeria, Zehetner, Claus
Publicado 2021